FDA Inspection 1164862 — Fresenius Kabi USA, LLC

Fresenius Kabi USA, LLC — FEI 3014732157

The FDA completed an inspection of Fresenius Kabi USA, LLC on March 18, 2022 in North Andover, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 18, 2022
Fiscal Year
2022
Product Type
Devices
Project Area
Compliance: Devices
Location
North Andover, MA (United States)

Citations

IDCFRDescription
1471621 CFR 820.30(f)Design verification - output does not meet input requirement